Literature DB >> 27867983

A liberal glycemic target in critically ill patients with poorly controlled diabetes?

Jan Gunst1, Greet Van den Berghe1.   

Abstract

Entities:  

Year:  2016        PMID： 27867983      PMCID： PMC5104654          DOI： 10.21037/atm.2016.10.28

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  25 in total

1.  Pre-morbid glycemic control modifies the interaction between acute hypoglycemia and mortality.

Authors:  Moritoki Egi; James S Krinsley; Paula Maurer; Devendra N Amin; Tomoyuki Kanazawa; Shruti Ghandi; Kiyoshi Morita; Michael Bailey; Rinaldo Bellomo
Journal:  Intensive Care Med       Date:  2016-02-03       Impact factor: 17.440

2.  Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality.

Authors:  Mark P Plummer; Rinaldo Bellomo; Caroline E Cousins; Christopher E Annink; Krishnaswamy Sundararajan; Benjamin A J Reddi; John P Raj; Marianne J Chapman; Michael Horowitz; Adam M Deane
Journal:  Intensive Care Med       Date:  2014-04-24       Impact factor: 17.440

3.  Hypoglycaemic counter-regulation at normal blood glucose concentrations in patients with well controlled type-2 diabetes.

Authors:  G Spyer; A T Hattersley; I A MacDonald; S Amiel; K M MacLeod
Journal:  Lancet       Date:  2000-12-09       Impact factor: 79.321

4.  Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study.

Authors:  Dirk Vlasselaers; Ilse Milants; Lars Desmet; Pieter J Wouters; Ilse Vanhorebeek; Ingeborg van den Heuvel; Dieter Mesotten; Michael P Casaer; Geert Meyfroidt; Catherine Ingels; Jan Muller; Sophie Van Cromphaut; Miet Schetz; Greet Van den Berghe
Journal:  Lancet       Date:  2009-01-26       Impact factor: 79.321

5.  Safety and efficacy of intensive insulin therapy in critical neurosurgical patients.

Authors:  Federico Bilotta; Remo Caramia; Francesca P Paoloni; Roberto Delfini; Giovanni Rosa
Journal:  Anesthesiology       Date:  2009-03       Impact factor: 7.892

6.  The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial.

Authors:  Federico Bilotta; Allison Spinelli; Federico Giovannini; Andrea Doronzio; Roberto Delfini; Giovanni Rosa
Journal:  J Neurosurg Anesthesiol       Date:  2007-07       Impact factor: 3.956

7.  Eliminating the diabetic disadvantage: the Portland Diabetic Project.

Authors:  Anthony P Furnary; YingXing Wu
Journal:  Semin Thorac Cardiovasc Surg       Date:  2006

8.  Glycemic control, diabetic status, and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemic management: six and one-half years experience at a university-affiliated community hospital.

Authors:  James S Krinsley
Journal:  Semin Thorac Cardiovasc Surg       Date:  2006

9.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

10.  Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial.

Authors:  Djillali Annane; Alain Cariou; Virginie Maxime; Elie Azoulay; Gilles D'honneur; Jean François Timsit; Yves Cohen; Michel Wolf; Muriel Fartoukh; Christophe Adrie; Charles Santré; Pierre Edouard Bollaert; Armelle Mathonet; Roland Amathieu; Alexis Tabah; Christophe Clec'h; Julien Mayaux; Julie Lejeune; Sylvie Chevret
Journal:  JAMA       Date:  2010-01-27       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.